Lataa...

The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer

BACKGROUND: Nonadherence to hormonal therapy is common and is associated with increased copayment amount. We investigated the change in adherence after the introduction of generic aromatase inhibitors (AIs) in 2010. METHODS: Using deidentified pharmacy and claims data from OptumInsight, we identifie...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Natl Cancer Inst
Päätekijät: Hershman, Dawn L., Tsui, Jennifer, Meyer, Jay, Glied, Sherry, Hillyer, Grace Clarke, Wright, Jason D., Neugut, Alfred I.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271034/
https://ncbi.nlm.nih.gov/pubmed/25349080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju319
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!